Skip to content
DraconiticResearch
Search Sources API
194,164 studies31 sourcesUpdated 29 min ago
Peer-reviewedLicence not statedJAMA

Finerenone in Patients With Chronic Kidney Disease Due to Glomerular Diseases

  • Brendon Lange Neuen1,2
  • Vlado Perkovic3
  • Rajiv Agarwal4
  • David Z.I. Cherney5
  • Carolyn S.P. Lam6,7
  • Christoph Wanner8
  • Katherine R. Tuttle9
  • Pantelis A. Sarafidis10
  • Jonathan Barratt11
  • Anna Marie Burgner12
  • Xiangmei Chen13,14
  • Alfredo Chew‐Wong15
88 more authors
  • Vladimir Dobronravov16
  • Jürgen Floege17
  • Kieran McCafferty18
  • Masaomi Nangaku19
  • David Packham20
  • Evangelos C. Papachristou21
  • Pablo E. Pérgola22
  • Marijn M. Speeckaert23
  • Arunkumar Subbiah24
  • Sydney C.W. Tang25,26
  • Shuifu Tang25,26
  • See Cheng Yeo27
  • Niels Jongs28
  • Johannes David Smeijer28
  • Mario Berger29
  • MEIKE DANIELA BRINKER30
  • Rania Dayoub31,32
  • Jay Elliott33
  • Na Li34
  • Katharina Mueller35
  • Nicole Rethemeier35
  • Marina Yael Finkelsztein36
  • Hiddo J.L. Heerspink37,2
  • FIND-CKD Investigators
  • Glenn Matthew Chertow14
  • Tim Friede14
  • Adeera Levin14
  • Johannes F.E. Mann14
  • Rafael Maldonado14
  • Paola Aguerre14
  • Paula Arenas14
  • Mariano Arriola14
  • Claudia Emilce Baccaro14
  • Maria Bevilacqua14
  • Julio Bittar14
  • Dafne Brodschi14
  • Julia Cáceres14
  • Gina Campestri14
  • Maria Cecilia Cantero14
  • Santiago Cardona14
  • Florencia Casan14
  • Evelin Cassini14
  • Gustavo Catalano14
  • Mariano I. Chahin14
  • Natalia Cluigt14
  • Ana Florencia Comes14
  • Pamela Delgado14
  • Maria Paula Dionisi14

60 listed; 100 in total.

37 affiliations
  1. 1Department of Renal Medicine, Royal North Shore Hospital, Sydney, New South Wales, Australia
  2. 2The George Institute for Global Health, University of New South Wales, Sydney, Australia
  3. 3University of New South Wales, Sydney, Australia
  4. 4Division of Nephrology, Richard L. Roudebush VA Medical Center and Indiana University School of Medicine, Indianapolis
  5. 5Division of Nephrology, University Health Network, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada
  6. 6Duke-National University of Singapore Medical School, Singapore, Singapore
  7. 7National Heart Centre Singapore, Singapore, Singapore
  8. 8Department of Clinical Research and Epidemiology, Comprehensive Heart Failure Center, University of Würzburg, Würzburg, Germany
  9. 9Providence Inland Northwest Health, University of Washington School of Medicine, Spokane
  10. 10First Department of Nephrology, Aristotle University of Thessaloniki, Hippokration Hospital, Thessaloniki, Greece
  11. 11Department of Cardiovascular Sciences, University of Leicester and Leicester General Hospital, Leicester, United Kingdom
  12. 12Division of Nephrology and Hypertension, Vanderbilt Health, Nashville, Tennessee
  13. 13Department of Nephrology, Chinese PLA General Hospital, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney and Urological Diseases, Beijing, China
  14. 14for the FIND-CKD Investigators
  15. 15San Cosme Clinic, Aguascalientes, Mexico
  16. 16Pavlov First Saint Petersburg State Medical University, St Petersburg, Russia
  17. 17Division of Nephrology and Rheumatology, Department of Cardiology, RWTH Aachen University Hospital, Aachen, Germany
  18. 18Barts Health NHS Trust, London, United Kingdom
  19. 19Division of Nephrology and Endocrinology, University of Tokyo Graduate School of Medicine, Tokyo, Japan
  20. 20The Royal Melbourne Hospital, Melbourne, Victoria, Australia
  21. 21Department of Nephrology and Kidney Transplantation, University Hospital of Patras, University of Patras, Patras, Greece
  22. 22Renal Associates, San Antonio, Texas
  23. 23Univeersiteit Gent, Gent, Belgium
  24. 24All India Institute of Medical Sciences, New Delhi, India
  25. 25Division of Nephrology, Department of Medicine, School of Clinical Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong, China
  26. 26The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine
  27. 27Department of Renal Medicine, Tan Tock Seng Hospital, Singapore, Singapore
  28. 28University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
  29. 29Bayer AG, Pharmaceuticals, Research and Development, Wuppertal, Germany
  30. 30Cardiology and Nephrology Clinical Development, Bayer AG, Wuppertal, Germany
  31. 31Children’s University Hospital (KUNO), University Hospital Regensburg, Regensburg, Germany
  32. 32Global Medical & Evidence CV and Heme, Bayer AG, Berlin, Germany
  33. 33Vertex Pharmaceuticals, Boston, Massachusetts
  34. 34Bayer Healthcare Company Limited, Beijing, China
  35. 35Clinical Statistics & Analytics, Research and Development, Bayer AG, Wuppertal, Germany
  36. 36EuroServices Bayer SL, Barcelona, Spain
  37. 37Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
Open at sourcePDFDOICite

Related

  1. Association of Finerenone Dose and Estimated Glomerular Filtration Rate (eGFR) Slope Changes in Patients With Diabetic Kidney Disease: A Real-World Retrospective Study.
    Hazuki Otani, Soichi Kurioka
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Efficacy and safety of finerenone in patients with chronic kidney disease: an individual participant data pooled analysis (INFINITY)
    Brendon Lange Neuen, Hiddo J.L. Heerspink, Vlado Perkovic +21
    The LancetPeer-reviewedLicence not stated21 citedGeneral medicineOpenAlex
  3. Real-World Renal Effects of Dapagliflozin in Bulgarian Patients with Chronic Kidney Disease of Predominantly Glomerular Origin: A Two-Year Comparative Cohort Study with Historical Controls
    Veronica Aladzhova, Teodora Ilieva, Bilyana Vasileva +8
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Real-world safety profile of finerenone in patients with type 2 diabetes and chronic kidney disease: a multi-database pharmacovigilance analysis of the FAERS and JADER systems
    Dan Zhang, Yun Zhao, Haiting Chen +1
    Frontiers in clinical diabetes and healthcarePeer-reviewedCC BYFull textPharmacology & toxicologyEurope PMCPMC
  5. Longitudinal kidney outcomes and safety after finerenone initiation in patients with non-diabetic chronic kidney disease: a single-center retrospective cohort study
    Xuejuan Sun, Juan Pei, Xing Chen +6
    Frontiers in medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMCPMCEurope PMC

Cite

BibTeXRIS
BibTeX
@article{neuen2026finerenone,
  title = {{Finerenone in Patients With Chronic Kidney Disease Due to Glomerular Diseases}},
  author = {Brendon Lange Neuen and Vlado Perkovic and Rajiv Agarwal and David Z.I. Cherney and Carolyn S.P. Lam and Christoph Wanner and Katherine R. Tuttle and Pantelis A. Sarafidis and Jonathan Barratt and Anna Marie Burgner and Xiangmei Chen and Alfredo Chew‐Wong and Vladimir Dobronravov and Jürgen Floege and Kieran McCafferty and Masaomi Nangaku and David Packham and Evangelos C. Papachristou and Pablo E. Pérgola and Marijn M. Speeckaert and Arunkumar Subbiah and Sydney C.W. Tang and Shuifu Tang and See Cheng Yeo and Niels Jongs and Johannes David Smeijer and Mario Berger and MEIKE DANIELA BRINKER and Rania Dayoub and Jay Elliott and Na Li and Katharina Mueller and Nicole Rethemeier and Marina Yael Finkelsztein and Hiddo J.L. Heerspink and FIND-CKD Investigators and Glenn Matthew Chertow and Tim Friede and Adeera Levin and Johannes F.E. Mann and Rafael Maldonado and Paola Aguerre and Paula Arenas and Mariano Arriola and Claudia Emilce Baccaro and Maria Bevilacqua and Julio Bittar and Dafne Brodschi and Julia Cáceres and Gina Campestri and Maria Cecilia Cantero and Santiago Cardona and Florencia Casan and Evelin Cassini and Gustavo Catalano and Mariano I. Chahin and Natalia Cluigt and Ana Florencia Comes and Pamela Delgado and Maria Paula Dionisi},
  journal = {JAMA},
  year = {2026},
  month = jun,
  doi = {10.1001/jama.2026.9923},
  url = {https://orbi.uliege.be/handle/2268/346445},
}
RIS
TY  - JOUR
TI  - Finerenone in Patients With Chronic Kidney Disease Due to Glomerular Diseases
AU  - Brendon Lange Neuen
AU  - Vlado Perkovic
AU  - Rajiv Agarwal
AU  - David Z.I. Cherney
AU  - Carolyn S.P. Lam
AU  - Christoph Wanner
AU  - Katherine R. Tuttle
AU  - Pantelis A. Sarafidis
AU  - Jonathan Barratt
AU  - Anna Marie Burgner
AU  - Xiangmei Chen
AU  - Alfredo Chew‐Wong
AU  - Vladimir Dobronravov
AU  - Jürgen Floege
AU  - Kieran McCafferty
AU  - Masaomi Nangaku
AU  - David Packham
AU  - Evangelos C. Papachristou
AU  - Pablo E. Pérgola
AU  - Marijn M. Speeckaert
AU  - Arunkumar Subbiah
AU  - Sydney C.W. Tang
AU  - Shuifu Tang
AU  - See Cheng Yeo
AU  - Niels Jongs
AU  - Johannes David Smeijer
AU  - Mario Berger
AU  - MEIKE DANIELA BRINKER
AU  - Rania Dayoub
AU  - Jay Elliott
AU  - Na Li
AU  - Katharina Mueller
AU  - Nicole Rethemeier
AU  - Marina Yael Finkelsztein
AU  - Hiddo J.L. Heerspink
AU  - FIND-CKD Investigators
AU  - Glenn Matthew Chertow
AU  - Tim Friede
AU  - Adeera Levin
AU  - Johannes F.E. Mann
AU  - Rafael Maldonado
AU  - Paola Aguerre
AU  - Paula Arenas
AU  - Mariano Arriola
AU  - Claudia Emilce Baccaro
AU  - Maria Bevilacqua
AU  - Julio Bittar
AU  - Dafne Brodschi
AU  - Julia Cáceres
AU  - Gina Campestri
AU  - Maria Cecilia Cantero
AU  - Santiago Cardona
AU  - Florencia Casan
AU  - Evelin Cassini
AU  - Gustavo Catalano
AU  - Mariano I. Chahin
AU  - Natalia Cluigt
AU  - Ana Florencia Comes
AU  - Pamela Delgado
AU  - Maria Paula Dionisi
PY  - 2026
DA  - 2026/06/05
JO  - JAMA
DO  - 10.1001/jama.2026.9923
UR  - https://orbi.uliege.be/handle/2268/346445
SN  - 0002-9955
SN  - 0098-7484
SN  - 1538-3598
SN  - 2376-8118
ER  -